Zou W - Search Results

1

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer.

Xu C, Zou W, Zhang L, Xu R, Li Y, Feng Y, Zhao R, Wang Y, Liu X, Wang J. Xu C, et al. Among authors: zou w. Front Immunol. 2023 May 22;14:1162580. doi: 10.3389/fimmu.2023.1162580. eCollection 2023. Front Immunol. 2023. PMID: 37283762 Free PMC article.

2

The Role of Consolidative Radiotherapy after a Complete Response to Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results from a Systematic Review with a Meta-Analysis.

Hu C, Deng C, Zou W, Zhang G, Wang J. Hu C, et al. Among authors: zou w. Acta Haematol. 2015;134(2):111-8. doi: 10.1159/000370096. Epub 2015 Apr 22. Acta Haematol. 2015. PMID: 25925586 Review.

3

Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.

Zhang L, Zou W. Zhang L, et al. Among authors: zou w. Mol Med Rep. 2015 Dec;12(6):7869-76. doi: 10.3892/mmr.2015.4443. Epub 2015 Oct 14. Mol Med Rep. 2015. PMID: 26497667 Free PMC article.

4

Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog.

Feng Y, Zhou S, Li G, Hu C, Zou W, Zhang H, Sun L. Feng Y, et al. Among authors: zou w. Arch Biochem Biophys. 2016 May 15;598:57-65. doi: 10.1016/j.abb.2016.03.019. Epub 2016 Apr 1. Arch Biochem Biophys. 2016. PMID: 27040383

5

Corrigendum to "Nuclear factor-κB-dependent microRNA-130a upregulation promotes cervical cancer cell growth by targeting phosphatase and tensin homolog" [Arch. Biochem. Biophys. 598 (2016) 57-65].

Feng Y, Zhou S, Li G, Hu C, Zou W, Zhang H, Sun L. Feng Y, et al. Among authors: zou w. Arch Biochem Biophys. 2016 Aug 1;603:131-133. doi: 10.1016/j.abb.2016.05.015. Arch Biochem Biophys. 2016. PMID: 27394037 No abstract available.

6

Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.

Feng Y, Zou W, Hu C, Li G, Zhou S, He Y, Ma F, Deng C, Sun L. Feng Y, et al. Among authors: zou w. Arch Biochem Biophys. 2017 Jun 1;623-624:20-30. doi: 10.1016/j.abb.2017.05.001. Epub 2017 May 8. Arch Biochem Biophys. 2017. PMID: 28495512

7

SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin.

Wang J, Feng Y, Chen X, Du Z, Jiang S, Ma S, Zou W. Wang J, et al. Among authors: zou w. J Cell Biochem. 2018 Feb;119(2):1733-1745. doi: 10.1002/jcb.26334. Epub 2017 Sep 18. J Cell Biochem. 2018. PMID: 28786507

8

Treatment Protocols for Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer.

Zou W, Hu C, Feng Y, Wang J. Zou W, et al. J Clin Oncol. 2018 Sep 20;36(27):2811-2812. doi: 10.1200/JCO.2018.78.8893. Epub 2018 Jun 13. J Clin Oncol. 2018. PMID: 29897830 No abstract available.

9

Antiangiogenic therapy for Wilms tumor in an adult and literature review.

Wang J, Fan S, Feng Y, Zhang H, Zou W, Hu C. Wang J, et al. Among authors: zou w. Anticancer Drugs. 2019 Jul;30(6):640-645. doi: 10.1097/CAD.0000000000000792. Anticancer Drugs. 2019. PMID: 30985306 Review.

10

Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.

Ma S, Wang J, Han Y, Guo F, Chen C, Chen X, Zou W. Ma S, et al. Among authors: zou w. Gynecol Oncol. 2019 Jul;154(1):246-252. doi: 10.1016/j.ygyno.2019.04.013. Epub 2019 Apr 18. Gynecol Oncol. 2019. PMID: 31005286 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,650 results

Search Page

Filters